Correlation of total serum HDL particles with a predictor of mortality risk in idiopathic pulmonary fibrosis.

Competing Interests: Conflict of interest: T. Yasuma reports grants from Shionogi, outside the submitted work. Conflict of interest: C.N. D'Alessandro-Gabazza reports grants from Shionogi Pharmaceutical Inc., Astellas Pharmaceuticals Inc. and Asahi Kassei, outside the submitted work. Conflict of interest: H. Fujimoto reports grants from Chugai, Pfizer, ONO, TAIHO, Boehringer Ingelheim and Eli Lilly, outside the submitted work. Conflict of interest: T. Kobayashi reports grants and personal fees from Chugai, Pfizer, ONO, Boehringer Ingelheim and Eli Lilly, grants from TAIHO, outside the submitted work. Conflict of interest: E.C. Gabazza reports grants from Shionogi Pharmaceutical Inc., Astellas Pharmaceuticals Inc. and Asahi Kassei, outside the submitted work.